Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNotes PayablesOther Non-Current AssetsPayablesPrepaid AssetsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Stemtech (STEK) Notes Payables (2020 - 2025)

Historic Notes Payables for Stemtech (STEK) over the last 6 years, with Q3 2025 value amounting to $2.4 million.

  • Stemtech's Notes Payables changed N/A to $2.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $2.4 million, marking a year-over-year change of. This contributed to the annual value of $2.0 million for FY2024, which is 6005.33% up from last year.
  • Stemtech's Notes Payables amounted to $2.4 million in Q3 2025.
  • In the past 5 years, Stemtech's Notes Payables registered a high of $2.4 million during Q2 2025, and its lowest value of $446246.0 during Q4 2022.
  • Moreover, its 5-year median value for Notes Payables was $1.5 million (2022), whereas its average is $1.6 million.
  • Its Notes Payables has fluctuated over the past 5 years, first tumbled by 6501.06% in 2022, then surged by 18646.2% in 2023.
  • Stemtech's Notes Payables (Quarter) stood at $1.3 million in 2021, then tumbled by 65.01% to $446246.0 in 2022, then surged by 186.46% to $1.3 million in 2023, then skyrocketed by 60.05% to $2.0 million in 2024, then increased by 15.41% to $2.4 million in 2025.
  • Its last three reported values are $2.4 million in Q3 2025, $2.4 million for Q2 2025, and $2.4 million during Q1 2025.